FDA Rx Risk Advisor Seligman Joins From DoE, Reports To CDER's Galson
Executive Summary
Department of Energy Deputy Assistant Secretary for Health Studies Paul Seligman, MD, will handle pharmaceutical risk management initiatives at FDA in his new position as senior advisor.